OPTINOSE, INC. Deferred Tax Assets, in Process Research and Development
OPTINOSE, INC. had Deferred Tax Assets, in Process Research and Development of $2.46 million as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2025-03-26
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $2.46M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $2.46M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $2.46M.
- 2021-12-31: Deferred Tax Assets, in Process Research and Development $2.46M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2024-12-31 | $2.46M 10-K · filed 2025-03-26 |
| 2023-12-31 | $2.46M 10-K · filed 2025-03-26 |
| 2022-12-31 | $2.46M 10-K · filed 2024-03-07 |
| 2021-12-31 | $2.46M 10-K · filed 2023-03-07 |
| 2020-12-31 | $2.48M 10-K · filed 2022-03-08 |
| 2019-12-31 | $2.48M 10-K · filed 2021-03-03 |
| 2018-12-31 | $2.48M 10-K · filed 2020-03-05 |
| 2017-12-31 | $2.48M 10-K · filed 2019-03-06 |
| 2016-12-31 | $2.18M 10-K · filed 2018-03-13 |